Diet-Derived MicroRNAs: Separating the Dream from Reality

• Authors: Katherine A. Cottrill , Stephen Y. Chan
• Languages of publication: EN

Abstracts

EN

Background: Both pleiotropic and ubiquitous, microRNAs (miRNAs) exert control over a wide range of cellular functions. They have been detected in virtually every extracellular fluid in the mammalian body, and many circulate substantial anatomical distances in plasma. Thus, secreted miRNAs are valuable not only as diagnostic tools but also may serve as novel biological effectors that can be transmitted between source and recipient tissue. Design: This review will discuss the possibility of delivering functional miRNAs from exogenously derived dietary sources. We will examine prior research interrogating the existence and relevance of such a mechanism. Findings: Recent findings have reported cross-kingdom transfer of specific plant-derived miRNAs to mammalian tissue following consumption of plant-based foods. These exogenous miRNAs were reported to be active in the recipient organisms, directing changes in gene expression at distant organ sites. In spite of this, subsequent studies have been unable to find evidence of substantial exogenous diet-derived miRNAs in mammalian circulation or tissues, regardless of diet. Conclusion: Further examination of diet-derived miRNA uptake is ongoing, but it does not appear that horizontal delivery of miRNAs via normal dietary intake is a generalizable or frequent process to maintain robust expression of these miRNAs in most higher-order animal organisms.

Keywords

EN

microRNA; nutrition; cross-kingdom delivery; diet

• Publisher: De Gruyter Open
• Journal: microRNA Diagnostics and Therapeutics
• Year: 2014
• Volume: 1
• Issue: 1

Dates

published

1 - 1 - 2014

online

24 - 4 - 2014

received

29 - 8 - 2013

accepted

30 - 12 - 2013

Contributors

author

Katherine A. Cottrill

• Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

author

Stephen Y. Chan

• Brigham and Women’s Hospital, New Research Building, Room 630N, 77 Avenue Louis Pasteur, Boston, Massachusetts, USA, 02115, Tel: [phone], Fax: [phone]

References

• [1] Chan SY, Loscalzo J. MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 2010; 9:1072-1083.[Crossref]
• [2] Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12:861-874.[Crossref][PubMed]
• [3] Berezikov E, Guryev V, van de Belt J, et al. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005; 120:21-24.[Crossref]
• [4] Huang X, Liang M, Dittmar R, et al. Extracellular MicroRNAs in Urologic Malignancies: Chances and Challenges. Int J Mol Sci 2013; 14:14785-14799.[Crossref][PubMed]
• [5] Hubers AJ, Prinsen CF, Sozzi G, et al. Molecular sputum analysis for the diagnosis of lung cancer. Br J Cancer 2013; 109:530-537.[PubMed][Crossref]
• [6] Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141:672-675.
• [7] Wu W, Hu Z, Qin Y, et al. Seminal plasma microRNAs: potential biomarkers for spermatogenesis status. Mol Hum Reprod 2012; 18:489-497.[Crossref][PubMed]
• [8] Xie Z, Chen G, Zhang X, et al. Salivary microRNAs as promising biomarkers for detection of esophageal cancer. PLoS One 2013; 8:e57502.[Crossref]
• [9] Yi Z, Fu Y, Ji R, et al. Altered microRNA signatures in sputum of patients with active pulmonary tuberculosis. PLoS One 2012; 7:e43184.[Crossref]
• [10] Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105:10513-10518.[Crossref]
• [11] Walter DH, Haendeler J, Reinhold J, et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 2005; 97:1142-1151.[Crossref]
• [12] Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010; 107:810-817.
• [13] Babin PJ, Gibbons GF. The evolution of plasma cholesterol: direct utility or a “spandrel” of hepatic lipid metabolism? Prog Lipid Res 2009; 48:73-91.[Crossref]
• [14] Brown WV. High-density lipoprotein and transport of cholesterol and triglyceride in blood. J Clin Lipidol 2007; 1:7-19.[Crossref]
• [15] Turchinovich A, Burwinkel B. Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. RNA Biol 2012; 9:1066-1075.[Crossref]
• [16] Kosaka N, Iguchi H, Yoshioka Y, et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010; 285:17442-17452.
• [17] Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2011; 2:282.[Crossref]
• [18] Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 2010; 107:6328-6333.[Crossref]
• [19] Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011; 13:423-433.[Crossref]
• [20] Zhang Y, Liu D, Chen X, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010; 39:133-144.
• [21] Zhang L, Hou D, Chen X, et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of crosskingdom regulation by microRNA. Cell Res 2012; 22:107-126.
• [22] Jiang M, Sang X, Hong Z. Beyond nutrients: food-derived microRNAs provide cross-kingdom regulation. Bioessays 2012; 34:280-284.[Crossref]
• [23] Snow JW, Hale A, Isaacs SK, et al. Ineffective delivery of diet-derived microRNAs to recipient animal organisms. RNA Biol 2013; 10.[Crossref]
• [24] Witwer KW, McAlexander MA, Queen SE, et al. Real-time quantitative PCR and droplet digital PCR for plant miRNAs in mammalian blood provide little evidence for general uptake of dietary miRNAs: Limited evidence for general uptake of dietary plant xenomiRs. RNA Biol 2013; 10.[Crossref]
• [25] Du T, Zamore PD. microPrimer: the biogenesis and function of microRNA. Development 2005; 132:4645-4652.
• [26] Cheng HH, Yi HS, Kim Y, et al. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One 2013; 8:e64795.[Crossref]
• [27] Pritchard CC, Kroh E, Wood B, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 2012; 5:492-497.[Crossref]
• [28] Hanke M, Hoefig K, Merz H, et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 2010; 28:655-661.[Crossref][PubMed]
• [29] Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010; 127:118-126.[Crossref]
• [30] Moussay E, Wang K, Cho JH, et al. MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2011; 108:6573-6578.[Crossref]
• [31] Park NJ, Zhou H, Elashoff D, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 2009; 15:5473-5477.[Crossref]
• [32] Roth P, Wischhusen J, Happold C, et al. A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem 2011; 118:449-457.[Crossref]
• [33] Zhao H, Shen J, Medico L, et al. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 2010; 5:e13735.[Crossref]
• [34] Fichtlscherer S, Zeiher AM, Dimmeler S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 2011; 31:2383-2390.[Crossref]
• [35] Tijsen AJ, Creemers EE, Moerland PD, et al. MiR423-5p as a circulating biomarker for heart failure. Circ Res 2010; 106:1035-1039.
• [36] Wang HJ, Zhang PJ, Chen WJ, et al. Characterization and Identification of novel serum microRNAs in sepsis patients with different outcomes. Shock 2013; 39:480-487.[Crossref]
• [37] Chen YJ, Zhu JM, Wu H, et al. Circulating microRNAs as a Fingerprint for Liver Cirrhosis. PLoS One 2013; 8:e66577.[Crossref]
• [38] van Rooij E, Sutherland LB, Qi X, et al. Control of stressdependent cardiac growth and gene expression by a microRNA. Science 2007; 316:575-579.
• [39] Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010; 31:659-666.[Crossref]
• [40] Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009; 2:ra81.
• [41] Muller G, Schneider M, Biemer-Daub G, et al. Microvesicles released from rat adipocytes and harboring glycosylphosphatidylinositol- anchored proteins transfer RNA stimulating lipid synthesis. Cell Signal 2011; 23:1207-1223.[Crossref]
• [42] Hergenreider E, Heydt S, Treguer K, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012; 14:249-256.[Crossref]
• [43] Zhuang G, Wu X, Jiang Z, et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J 2012; 31:3513-3523.[Crossref]
• [44] Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967; 13:269-288.[Crossref]
• [45] Abrahams VM, Straszewski SL, Kamsteeg M, et al. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res 2003; 63:5573-5581.
• [46] Mack M, Kleinschmidt A, Bruhl H, et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 2000; 6:769-775.
• [47] Martinez MC, Tesse A, Zobairi F, et al. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 2005; 288:H1004-1009.
• [48] Morel O, Toti F, Hugel B, et al. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 2004; 11:156-164.[Crossref]
• [49] Ratajczak J, Miekus K, Kucia M, et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006; 20:847-856.[Crossref]
• [50] Ratajczak J, Wysoczynski M, Hayek F, et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20:1487-1495.[Crossref]
• [51] Sloand EM, Maciejewski JP, Dunn D, et al. Correction of the PNH defect by GPI-anchored protein transfer. Blood 1998; 92:4439-4445.
• [52] Yuan A, Farber EL, Rapoport AL, et al. Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One 2009; 4:e4722.[Crossref]
• [53] Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008; 3:e3694.[Crossref]
• [54] Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654-659.[Crossref]
• [55] Wang K, Zhang S, Weber J, et al. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 2010; 38:7248-7259.[Crossref]
• [56] Ohshima K, Inoue K, Fujiwara A, et al. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One 2010; 5:e13247.[Crossref]
• [57] Pigati L, Yaddanapudi SC, Iyengar R, et al. Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One 2010; 5:e13515.[Crossref]
• [58] Rayner KJ, Hennessy EJ. Extracellular communication via microRNA: lipid particles have a new message. J Lipid Res 2013; 54:1174-1181.[Crossref]
• [59] Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 2011; 108:5003-5008.
• [60] Wagner J, Riwanto M, Besler C, et al. Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler Thromb Vasc Biol 2013; 33:1392-1400.[Crossref]
• [61] Issa Z, Grant WN, Stasiuk S, et al. Development of methods for RNA interference in the sheep gastrointestinal parasite, Trichostrongylus colubriformis. Int J Parasitol 2005; 35:935-940.[Crossref]
• [62] Newmark PA, Reddien PW, Cebria F, et al. Ingestion of bacterially expressed double-stranded RNA inhibits gene expression in planarians. Proc Natl Acad Sci U S A 2003; 100 Suppl 1:11861-11865.[Crossref]
• [63] Timmons L, Fire A. Specific interference by ingested dsRNA. Nature 1998; 395:854.
• [64] Feinberg EH, Hunter CP. Transport of dsRNA into cells by the transmembrane protein SID-1. Science 2003; 301:1545-1547.
• [65] Winston WM, Sutherlin M, Wright AJ, et al. Caenorhabditis elegans SID-2 is required for environmental RNA interference. Proc Natl Acad Sci U S A 2007; 104:10565-10570.
• [66] Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391:806-811.
• [67] Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000; 403:901-906.
• [68] Mao YB, Cai WJ, Wang JW, et al. Silencing a cotton bollworm P450 monooxygenase gene by plant-mediated RNAi impairs larval tolerance of gossypol. Nat Biotechnol 2007; 25:1307-1313.
• [69] Sattar S, Addo-Quaye C, Song Y, et al. Expression of small RNA in Aphis gossypii and its potential role in the resistance interaction with melon. PLoS One 2012; 7:e48579.[Crossref]
• [70] Qu F, Morris TJ. Suppressors of RNA silencing encoded by plant viruses and their role in viral infections. FEBS Lett 2005; 579:5958-5964.
• [71] Lecellier CH, Dunoyer P, Arar K, et al. A cellular microRNA mediates antiviral defense in human cells. Science 2005; 308:557-560.
• [72] Xiang S, Fruehauf J, Li CJ. Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nat Biotechnol 2006; 24:697-702.[Crossref]
• [73] Kosaka N, Izumi H, Sekine K, et al. microRNA as a new immuneregulatory agent in breast milk. Silence 2010; 1:7.
• [74] Young VB, Falkow S, Schoolnik GK. The invasin protein of Yersinia enterocolitica: internalization of invasin-bearing bacteria by eukaryotic cells is associated with reorganization of the cytoskeleton. J Cell Biol 1992; 116:197-207.[Crossref]
• [75] Grillot-Courvalin C, Goussard S, Huetz F, et al. Functional gene transfer from intracellular bacteria to mammalian cells. Nat Biotechnol 1998; 16:862-866.[Crossref]
• [76] Mathew E, Hardee GE, Bennett CF, et al. Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes. Gene Ther 2003; 10:1105-1115.[Crossref]
• [77] Munch EM, Harris RA, Mohammad M, et al. Transcriptome profiling of microRNA by Next-Gen deep sequencing reveals known and novel miRNA species in the lipid fraction of human breast milk. PLoS One 2013; 8:e50564.[Crossref]
• [78] Izumi H, Kosaka N, Shimizu T, et al. Bovine milk contains microRNA and messenger RNA that are stable under degradative conditions. J Dairy Sci 2012; 95:4831-4841.[Crossref]
• [79] Admyre C, Johansson SM, Qazi KR, et al. Exosomes with immune modulatory features are present in human breast milk. J Immunol 2007; 179:1969-1978
• [80] Van de Perre P. Transfer of antibody via mother’s milk. Vaccine 2003; 21:3374-3376.
• [81] Garcia CK, Wilund K, Arca M, et al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 2001; 292:1394-1398.
• [82] Yu B, Yang Z, Li J, et al. Methylation as a crucial step in plant microRNA biogenesis. Science 2005; 307:932-935.
• [83] Wang K, Li H, Yuan Y, et al. The complex exogenous RNA spectra in human plasma: an interface with human gut biota? PLoS One 2012; 7:e51009.[Crossref]
• [84] Duxbury MS, Ashley SW, Whang EE. RNA interference: a mammalian SID-1 homologue enhances siRNA uptake and gene silencing efficacy in human cells. Biochem Biophys Res Commun 2005; 331:459-463.
• [85] Zhang Y, Wiggins BE, Lawrence C, et al. Analysis of plantderived miRNAs in animal small RNA datasets. BMC Genomics 2012; 13:381.[Crossref]
• [86] Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-233.
• [87] Dickinson B, Zhang Y, Petrick JS, Heck G, Ivashuta S, Marshall WS. Lack of detectable oral bioavailability of plant microRNAs after feeding in mice. Nat Biotechnol 2013; 31:965-967.[Crossref]
• [88] Munafo DB, Robb GB. Optimization of enzymatic reaction conditions for generating representative pools of cDNA from small RNA. RNA 2010; 16:2537-2552.[Crossref]
• [89] Chen X, Zen K, Zhang CY. Reply to Lack of detectable oral bioavailability of plant microRNAs after feeding in mice. Nat Biotechnol 2013; 31:943.
• [90] Brown BD, Gentner B, Cantore A, et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 2007; 25:1457-1467.[Crossref]
• [91] Petrick JS, Brower-Toland B, Jackson AL, et al. Safety assessment of food and feed from biotechnology-derived crops employing RNA-mediated gene regulation to achieve desired traits: a scientific review. Regul Toxicol Pharmacol 2013; 66:167-176.[Crossref]
• [92] van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368:407-415.
• [93] Wilson DS, Dalmasso G, Wang L, et al. Orally delivered thioketal nanoparticles loaded with TNF-alpha-siRNA target inflammation and inhibit gene expression in the intestines. Nat Mater 2010; 9:923-928.[Crossref]
• [94] Tabara H, Grishok A, Mello CC. RNAi in C. elegans: soaking in the genome sequence. Science 1998; 16; 282:430-431.

Identifiers

DOI

10.2478/micrnat-2014-0001